CLINICAL_TRIALS
trial_result
· 2017-03-27
Clinical Trial Update: Characterization of Myocardial Blood Flow Measurements Using Lexiscan®™ (Regadenoson) (Lexiscan®™) Rubidium-82 Myocardial Perfusion PET: A Temporal-Dependency Investigation [Phase 4]
Summary
Phase 4 trial assessing temporal dependency of myocardial blood flow measurements using regadenoson and Rubidium-82 PET.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Timothy M. Bateman, MD | Conditions: Myocardial Blood Flow Reserve | Phase 4 | Status: COMPLETED | Results posted: 2017-03-27